Trials / Recruiting
RecruitingNCT07100561
30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Komfo Anokye Teaching Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extensive post discharge counselling and phone-based follow up | Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90. |
Timeline
- Start date
- 2025-07-14
- Primary completion
- 2026-03-31
- Completion
- 2026-06-30
- First posted
- 2025-08-03
- Last updated
- 2025-08-03
Locations
1 site across 1 country: Ghana
Source: ClinicalTrials.gov record NCT07100561. Inclusion in this directory is not an endorsement.